Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -1.1x - -1.2x | -1.1x |
| Historical Pb Multiple | -12.3x - -1.4x | -4.4x |
| Fair Value | €0.028 - €0.031 | €0.029 |
| Upside | 7.1% - 18.4% | 12.7% |
| Benchmarks | - | Full Ticker |
| genedrive plc | - | AIM:GDR |
| Physiomics Plc | - | AIM:PYC |
| Oxford BioDynamics Plc | - | AIM:OBD |
| Diaceutics PLC | - | AIM:DXRX |
| Oxford Nanopore Technologies plc | - | LSE:ONT |
| Proteome Sciences plc | - | DB:PI2 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| GDR | PYC | OBD | DXRX | ONT | PI2 | |||
| AIM:GDR | AIM:PYC | AIM:OBD | AIM:DXRX | LSE:ONT | DB:PI2 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | -47.4% | -40.6% | -6.8% | 2.5% | 5.4% | -39.4% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -3177.5% | -49.4% | -2050.7% | 0.3% | -78.8% | -14.4% | ||
| Prior Fiscal Year | -9363.6% | -78.8% | -2122.7% | -7.4% | -91.1% | -48.6% | ||
| Latest Fiscal Year | -1412.2% | -106.8% | -1818.7% | -5.3% | -79.8% | -69.7% | ||
| Latest Twelve Months | -1201.5% | -116.9% | -1818.7% | -5.3% | -79.8% | -69.7% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -212.7% | -48.9% | -121.0% | -0.2% | -21.9% | NA | ||
| Prior Fiscal Year | -134.6% | -63.4% | -250.5% | -4.2% | -23.1% | NM | ||
| Latest Twelve Months | -321.9% | -116.4% | -222.2% | -4.2% | -23.8% | NM | ||
| Next Fiscal Year | #NUM! | 12832.6% | 701.6% | 1.0% | -27.9% | #NUM! | ||
| Two Fiscal Years Forward | 453.0% | 116.2% | 79.6% | 9.2% | -28.1% | 41.4% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 15.3x | 2.8x | 12.3x | 3.1x | 6.3x | 1.8x | ||
| Price / LTM EPS | -1.3x | -2.4x | -0.7x | -58.1x | -7.9x | -2.6x | ||
| Price / Book | 3.1x | 3.6x | 1.8x | 2.5x | 2.0x | -1.4x | ||
| Price / Fwd Book | 1.7x | -5.2x | -1.0x | 2.5x | 2.6x | -1.0x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 1.8x | 2.5x | 3.6x | |||||
| Historical P/B Ratio | -12.3x | -4.4x | -1.4x | |||||
| Selected P/B Multiple | -1.1x | -1.1x | -1.2x | |||||
| (x) Book Value | (7) | (7) | (7) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | GDR | PYC | OBD | DXRX | ONT | PI2 | |
| Value of Common Equity | 9 | 2 | 8 | 99 | 1,151 | 7 | |
| (/) Shares Outstanding | 624.9 | 303.2 | 1,957.6 | 84.5 | 961.0 | 295.2 | |
| Implied Stock Price | 0.02 | 0.01 | 0.00 | 1.17 | 1.20 | 0.02 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.86 | |
| Implied Stock Price (Trading Cur) | 0.02 | 0.01 | 0.00 | 1.17 | 1.20 | 0.03 | |
| Trading Currency | GBP | GBP | GBP | GBP | GBP | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.86 | |